• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Driving Performance and Cannabis Users’ Perception of Safety: A Randomized Trial
RESEARCH UPDATE

Driving Performance and Cannabis Users’ Perception of Safety: A Randomized Trial

January 30, 2023
Olaniyi Olayinka, MD.
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Olaniyi Olayinka, MD. Dr. Olayinka has no financial relationships with companies related to this material.

REVIEW OF: Marcotte TD et al, JAMA Psychiatry 2022;79(3):201–209

STUDY TYPE: Double-blind, placebo-controlled parallel randomized clinical trial

Everyone knows that driving while under the influence of alcohol is dangerous. But what about cannabis? The effect of cannabis on driving ability is not well understood but is becoming increasingly relevant as cannabis laws are liberalized around the nation. Researchers designed a double-blind placebo-controlled trial to determine how THC affects driving ability and how long its effects last.

The study recruited 191 participants who had used cannabis ≥4 times in the past month. Sixty-two percent were male, 43% were non-Hispanic White, and ages ranged from 21 to 55. Participants abstained from cannabis for at least 48 hours and then were randomly assigned to one of three groups: low THC, high THC, or placebo.

On testing day, participants were given cannabis cigarettes and instructed to smoke “as you would at home.” The THC content of the cannabis was 13.4% in the high THC group (comparable to typical whole-plant cannabis purchased at dispensaries today), 5.9% in the low THC group, and 0.02% in the placebo group. Participants completed a driving simulation 30 minutes, 90 minutes, 3.5 hours, and 4.5 hours after smoking. The simulation lasted 25 minutes, emulated urban and city driving, and had challenges such as highway merging, driving while attending to an iPad mounted on the dashboard, and maintaining constant distance from a car being driven at varying speed. Performance was quantified by a Composite Drive Score (CDS), which takes variables like proper speed, time out of lane, and lateral position into account. Serum levels of THC were measured at the time of each driving simulation.

Not surprisingly, drivers in the placebo group had significantly better CDS scores than those in the THC groups. THC had a medium effect size on driving performance at 30 and 90 minutes, but performance was equivalent between groups at the 3.5- and 4.5-hour marks. The low THC and high THC groups had similar impairments in driving performance. Importantly, participants were asked about their subjective perception of their readiness to drive. At 30 minutes, 47.5% in the THC groups said they would drive at their current level of intoxication, and this increased to 68.6% at 1.5 hours.

There were a few limitations to this study. Most notably, 92% of participants correctly guessed whether they received THC. The study recruited healthy participants who regularly used cannabis, so the results may not be generalizable to inexperienced THC users or vulnerable populations (eg, the elderly or those with traumatic brain injury). THC effects could very well be more pronounced or longer lived in these individuals. Authors noted that CDS scores in this study are not directly comparable to impairments in driving for those under the influence of alcohol. For a rough point of comparison, the overall effect size is similar to what would be expected for a blood alcohol level between 0.05% and 0.08%.

Carlat Take

Cannabis consumption impairs driving, even if the THC content is on the low side, and subjective perception is not a good predictor of actual driving ability. Tell your patients who use cannabis to abstain from driving for at least three and a half hours after using, even if they feel safe to drive.

Research Update
KEYWORDS addiction cannabis marijuana THC
    Olaniyi Olayinka, MD.

    More from this author
    www.thecarlatreport.com
    Issue Date: January 31, 2023
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, Addiction Treatment in the ED, CATR, Jan/Feb/Mar 2023
    What to Know About Injectable Buprenorphine (Sublocade)
    Managing Alcohol Withdrawal in the Emergency Department
    Buprenorphine and Dental Issues
    Alcohol Use Disorder and Thiamine Supplementation
    Thiamine Supplementation in Patients With Alcohol Use Disorder
    Driving Performance and Cannabis Users’ Perception of Safety: A Randomized Trial
    Is Ibogaine Safe for Opioid Detox?
    CME Post-Test, Addiction Treatment in the ED, CATR, Jan/Feb/Mar 2023
    DOWNLOAD NOW
    Featured Book
    • HospPsychiatry_Spiral_Binding_Sm.png

      Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

      This comprehensive guide is designed to be a valuable resource for professionals working in...
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.